pcDNA3.1-CHRFAM7ADelta2bp-mGFP
(Plasmid
#62636)
-
Purposemammalian expression of human duplicated Alpha7-2 bp deletion (CHRFAM7A-∆2bp) with mGFP fused into M3-M4 loop
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 62636 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepcDNA3.1
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 5600
-
Vector typeMammalian Expression
-
Selectable markersHygromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)Top10
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameCHRFAM7A
-
Alt namedhAlpha7
-
Alt nameHuman Alpha7 neuronal nicotinic acetylcholine receptor gene with partial duplication
-
SpeciesH. sapiens (human)
-
Mutationthere is a 2-bp deletion in exon 6 of CHRFAM7A and this causes a frameshift in translation, mGFP inserted in M3-M4 loop
-
Entrez GeneCHRFAM7A (a.k.a. CHRNA7, CHRNA7-DR1, D-10, NACHRA7)
- Promoter CMV
Cloning Information
- Cloning method Unknown
- 5′ sequencing primer CMV-F
- 3′ sequencing primer BGH Reverse (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pcDNA3.1-CHRFAM7ADelta2bp-mGFP was a gift from Henry Lester (Addgene plasmid # 62636 ; http://n2t.net/addgene:62636 ; RRID:Addgene_62636) -
For your References section:
The duplicated alpha7 subunits assemble and form functional nicotinic receptors with the full-length alpha7. Wang Y, Xiao C, Indersmitten T, Freedman R, Leonard S, Lester HA. J Biol Chem. 2014 Sep 19;289(38):26451-63. doi: 10.1074/jbc.M114.582858. Epub 2014 Jul 23. 10.1074/jbc.M114.582858 PubMed 25056953